Mr Tyler Saunders, 1 George Square, Edinburgh, EH8 9JZ,
J Prev Alzheimers Dis. 2023;10(3):543-550. doi: 10.14283/jpad.2023.31.
In the absence of preventative pharmacological interventions for Alzheimer's Disease dementia, there is a growing interest in modifiable risk factors associated with AD. Such risk factors are thought to contribute up to 40% of the risk of dementia. The Lifestyle for Brain Health (LIBRA) index, a dementia risk score which focuses exclusively on modifiable factors, has been found to be associated with increased risk of dementia and cognitive decline. It is currently unclear how the LIBRA index relates to cerebrospinal fluid (CSF) biomarkers of Alzheimer's Disease.
To examine the association between LIBRA index scores and trajectories of phospho-tau 181 and total tau in the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS), and to examine whether these trajectories differ between participants with high and low CSF amyloid-beta 1-42 (Aβ42).
Analysis of CSF biomarker and LIBRA index scores from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study.
The European Prevention of Alzheimer's Dementia Longitudinal Cohort Study is a multi-centre, pan-European study.
Cerebrospinal fluid samples were taken by lumbar puncture and analysed using electrochemiluminescence. LIBRA index scores were calculated from self-reported variables, questionnaires, and physiological measurements.
In the total sample (n = 1715; mean age = 66.0, 56.4% female), there were no significant associations between LIBRA scores (mean = 0.73 points) and rate of change in cerebrospinal fluid biomarkers. In participants with high Aβ, reflecting less deposition in the brain, (n = 1134), LIBRA scores were significantly associated with the rate of change in total tau, where higher LIBRA scores (denoting higher dementia risk) were associated with increases in t-tau. There were no significant associations between LIBRA scores and change in cerebrospinal biomarkers in participants with low Aβ.
We found an association between modifiable risk factors and total tau accumulation in participants without dementia and without Aβ accumulation. This suggests that increasing levels of total tau may be driven by factors other than Aβ accumulation and highlights the need for developing and examining tau-targeting drugs in Alzheimer's Disease development.
在缺乏预防阿尔茨海默病痴呆的药物干预措施的情况下,人们对与 AD 相关的可改变风险因素越来越感兴趣。这些风险因素被认为占痴呆风险的 40%。专门针对可改变因素的痴呆风险评分生活方式对大脑健康(LIBRA)指数与痴呆和认知能力下降的风险增加有关。目前尚不清楚 LIBRA 指数与阿尔茨海默病的脑脊液(CSF)生物标志物有何关系。
检查 LIBRA 指数评分与欧洲预防阿尔茨海默病痴呆纵向队列研究(EPAD LCS)中磷酸化 tau181 和总 tau 的轨迹之间的关联,并检查这些轨迹是否在 CSF 淀粉样蛋白-β1-42(Aβ42)水平高和低的参与者之间存在差异。
对来自欧洲预防阿尔茨海默病痴呆纵向队列研究的 CSF 生物标志物和 LIBRA 指数评分进行分析。
欧洲预防阿尔茨海默病痴呆纵向队列研究是一项多中心、泛欧研究。
通过腰椎穿刺采集脑脊液样本,并使用电化学发光法进行分析。LIBRA 指数评分是根据自我报告的变量、问卷和生理测量值计算得出的。
在总样本(n=1715;平均年龄=66.0,56.4%为女性)中,LIBRA 评分(平均值=0.73 分)与脑脊液生物标志物的变化率之间没有显著关联。在 Aβ 水平较高的参与者中(反映大脑中沉积较少)(n=1134),LIBRA 评分与总 tau 的变化率显著相关,其中较高的 LIBRA 评分(表示更高的痴呆风险)与 t-tau 的增加相关。在 Aβ 水平较低的参与者中,LIBRA 评分与 CSF 生物标志物的变化之间没有显著关联。
我们发现,在没有痴呆且没有 Aβ 沉积的参与者中,可改变的风险因素与总 tau 的积累之间存在关联。这表明总 tau 的增加可能不是由 Aβ 积累引起的,这突显了在阿尔茨海默病发展中开发和检查针对 tau 的药物的必要性。